In this set of screening criteria, we reserved 118 index SNPs for the genetic prediction of PCa, 10 for BPH, 6 for IgA nephropathy, 4 for membranous nephropathy, 4 for nephrotic syndrome, 9 for kidney and ureter calculi, 5 for microalbumin in urine, 32 for urinary albumin excretion, 13 for potassium in urine, 20 for creatinine in urine, 29 for sodium in urine, 42 for serum creatinine (eGFRcrea), 4 for nephrotic syndrome, 4 for serum cystatin C (eGFRcys), and 12 for levels of kidney injury molecule 1. This evidence concerns the gene CST3 and benign prostatic hyperplasia.